Exhibit 99.1 FOR IMMEDIATE RELEASE Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance • Fourth quarter revenue increased 12% to $59.9 billion • Fourth quarter GAAP operating earnings were $401 million and GAAP diluted EPS was $0.96 • Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84 • Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billi ...

Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.Analysts expect the Dublin, Ohio-based company to report quarterly earnings at $1.73 per share, up from $1.55 per share in the year-ago period. Cardinal Health is expected to report quarterly revenue of $58.64 billion for the quarter, compared to $53.45 billion a year earlier, according to data from Benzinga Pro.On May 7, Cardinal Health approved an increase to its quarterly dividend ...

Cardinal Health, Inc. (CAH) is scheduled to report fourth-quarter fiscal 2024 results on Aug 14, before the opening bell.In the last reported quarter, the company delivered an earnings surprise of 6.67%. CAH’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 12.91%.Q4 EstimatesFor the fiscal fourth quarter, the consensus mark for earnings is pegged at $1.72 per share, indicating an improvement of 10.9% from the prior-year quarter’s reported ...

Analysts on Wall Street project that Cardinal Health (CAH) will announce quarterly earnings of $1.72 per share in its forthcoming report, representing an increase of 11% year over year. Revenues are projected to reach $58.72 billion, increasing 9.9% from the same quarter last year.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forec ...

The market expects Cardinal Health (CAH) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be release ...

In the latest market close, Cardinal Health (CAH) reached $99.52, with a +1.18% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 1.04% for the day. Elsewhere, the Dow saw an upswing of 0.76%, while the tech-heavy Nasdaq appreciated by 1.03%.The prescription drug distributor's shares have seen an increase of 1.53% over the last month, surpassing the Medical sector's gain of 0.21% and the S&P 500's loss of 6.74%.The investment community will be closely monitori ...

DNY59 CAH stock: unfavorable PEG ratio I last covered Cardinal Health (NYSE:CAH) stock a bit more than 3 months ago. As you can see from the chart below, my last article, titled "Cardinal Health: Solid Business But Overvalued", was published on April 18, 2024, and argued for a HOLD thesis on the stock. The holding rating was mainly based on the following considerations: Cardinal Health is overvalued, with a dividend yield lower than its historical average and a high P/E ratio. Growth projections for the ...

The latest trading session saw Cardinal Health (CAH) ending at $100.83, denoting a +0.57% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 1.08% for the day. Meanwhile, the Dow gained 0.75%, and the Nasdaq, a tech-heavy index, added 2.64%. Coming into today, shares of the prescription drug distributor had gained 3.85% in the past month. In that same time, the Medical sector gained 0.71%, while the S&P 500 lost 0.44%. Market participants will be closely fo ...

Cardinal Health (CAH) closed the latest trading day at $96.71, indicating a +0.91% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 2.32%. Elsewhere, the Dow saw a downswing of 1.25%, while the tech-heavy Nasdaq depreciated by 3.64%.The prescription drug distributor's shares have seen a decrease of 7.07% over the last month, not keeping up with the Medical sector's gain of 0.32% and the S&P 500's gain of 1.79%.Analysts and investors alike will be k ...

Cardinal Health’s (CAH) Presource kit plastic syringe makers Jiangsu Shenli Medical Production Co. Ltd and Jiangsu Caina have been facing FDA investigation. Recent inspections have unveiled multiple quality system violations, leading to warning letters and import alerts. CAH has recalled the affected products to ensure patient safety and compliance with FDA regulations.Following the recent warning, the import alert was expanded to preventJiangsu Shenli’s enteral syringes from entering the United States. The ...